Carotenoids, vitamin A, and their association with the metabolic syndrome: A systematic review and meta-analysis

Nutrition Reviews

Volumn 77, Issue 1, 2019, Pages 32-45

  Beydoun, M A ^a   Chen, X ^a   Jha, K ^b   Beydoun, H A ^c   Zonderman, A B ^d   Canas, J A ^e  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^c NEMOURS CHILDREN S CLINIC   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

carotenoids; meta analysis; metabolic syndrome; vitamin A.

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; AMYLOID A PROTEIN; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; LYCOPENE; MALONALDEHYDE; RETINOL; RETINOL ESTER; SELENIUM; SUPEROXIDE DISMUTASE; TOCOPHEROL; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ARTICLE; CASE CONTROL STUDY; COCHRANE LIBRARY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIETARY INTAKE; HUMAN; MEDLINE; METABOLIC SYNDROME X; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; META ANALYSIS;

CAROTENOIDS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; METABOLIC SYNDROME;

EID: 85058502218     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuy044     Document Type: Article

References (82)

1. Ford ES, Mokdad AH, Giles WH, et al. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346-2352.
2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83:25F-29F.
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
5. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062.
6. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812-819.
7. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
8. Appels CW, Vandenbroucke JP. Overweight, obesity, and mortality. N Engl J Med. 2006;355:2699; author reply 2700-2701.
9. Bender R, Zeeb H, Schwarz M, et al. Causes of death in obesity: relevant increase in cardiovascular but not in all-cancer mortality. J Clin Epidemiol. 2006;59:1064-1071.
10. Doig GS. Obesity-related excess mortality: what should we do now? Crit Care Med. 2004;32:1084-1085.
11. Ferrucci L, Alley D. Obesity, disability, and mortality: a puzzling link. Arch Intern Med. 2007;167:750-751.
12. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr. 1997;66:1044S-1050S.
13. Stevens J. Obesity mortality in Africans-Americans. Nutr Rev. 2000;58:346-353.
14. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31:S663-S667.
15. Hill JO, Sallis JF, Peters JC. Economic analysis of eating and physical activity: a next step for research and policy change. Am J Prev Med. 2004;27:111-116.
16. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6:97-106.
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
18. Beydoun MA, Shroff MR, Chen X, et al. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr. 2011;141:903-913.
19. Zimmermann MB, Aeberli I. Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review. Int J Obes (Lond). 2008;32(suppl 6): S11-S18.
20. Dakshinamurti K. Vitamins and their derivatives in the prevention and treatment of metabolic syndrome diseases (diabetes). Can J Physiol Pharmacol. 2015;93:355-362.
21. Leermakers ET, Darweesh SK, Baena CP, et al. The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis. Am J Clin Nutr. 2016;103:481-494.
22. de Toro-Martin J, Arsenault BJ, Despres JP, et al. Precision nutrition: a review of personalized nutritional approaches for the prevention and management of metabolic syndrome. Nutrients. 2017;9:pii E913.
23. Bonet ML, Canas JA, Ribot J, et al. Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch Biochem Biophys. 2015;572:112-125.
24. Soory M. Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. Infect Disord Drug Targets. 2009;9:400-414.
25. Campbell DR, Gross MD, Martini MC, et al. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev. 1994;3:493-500.
26. Stryker WS, Kaplan LA, Stein EA, et al. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol. 1988;127:283-296.
27. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res. 2007;55:207-216.
28. Voutilainen S, Nurmi T, Mursu J, et al. Carotenoids and cardiovascular health. Am J Clin Nutr. 2006;83:1265-1271.
29. Montonen J, Knekt P, Jarvinen R, et al. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care. 2004;27:362-366.
30. Coyne T, Ibiebele TI, Baade PD, et al. Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr. 2005;82:685-693.
31. Ford ES, Will JC, Bowman BA, et al. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1999;149:168-176.
32. Hozawa A, Jacobs DR Jr, Steffes MW, et al. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol. 2006;163:929-937.
33. Reunanen A, Knekt P, Aaran RK, Aromaa A. Serum antioxidants and risk of noninsulin dependent diabetes mellitus. Eur J Clin Nutr. 1998;52:89-93.
34. Kataja-Tuomola M, Sundell JR, Mannisto S, et al. Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Diabetologia. 2008;51:47-53.
35. Liu S, Ajani U, Chae C, et al. Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA. 1999;282:1073-1075.
36. Wang L, Liu S, Pradhan AD, et al. Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women. Am J Epidemiol. 2006;164:576-585.
37. Wang L, Liu S, Manson JE, et al. The consumption of lycopene and tomato-based food products is not associated with the risk of type 2 diabetes in women. J Nutr. 2006;136:620-625.
38. Grune T, Lietz G, Palou A, et al. Beta-carotene is an important vitamin A source for humans. J Nutr. 2010;140:2268S-2285S.
39. Khillan JS. Vitamin A/retinol and maintenance of pluripotency of stem cells. Nutrients. 2014;6:1209-1222.
40. Sugiura M, Nakamura M, Ogawa K, et al. Associations of serumcarotenoid concentrations with the metabolic syndrome: interaction with smoking. Br J Nutr. 2008;100:1297-1306.
41. Coyne T, Ibiebele TI, Baade PD, et al. Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia. Br J Nutr. 2009;102:1668-1677.
42. Czernichow S, Vergnaud AC, Galan P, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009;90:329-335.
43. Suzuki K, Ito Y, Inoue T, Hamajima N. Inverse association of serum carotenoids with prevalence of metabolic syndrome among Japanese. Clin Nutr. 2011;30:369-375.
44. Liu J, Shi WQ, Cao Y, et al. Higher serum carotenoid concentrations associated with a lower prevalence of the metabolic syndrome in middle-aged and elderly Chinese adults. Br J Nutr. 2014;112:2041-2048.
45. Sugiura M, Nakamura M, Ogawa K, et al. High serum carotenoids associated with lower risk for the metabolic syndrome and its components among Japanese subjects: Mikkabi cohort study. Br J Nutr. 2015;114:1674-1682.
46. Han GM, Soliman GA, Meza JL, et al. The influence of BMI on the association between serum lycopene and the metabolic syndrome. Br J Nutr. 2016;115:1292-1300.
47. Sharma P, Mishra S, Ajmera P, et al. Oxidative stress in metabolic syndrome. Indian J Clin Biochem. 2005;20:145-149.
48. Suriyaprom K, Phonrat B, Satitvipawee P, et al. Homocysteine but not serum amyloid A, vitamin A and E related to increased risk of metabolic syndrome in postmenopausal Thai women. Int J Vitam Nutr Res. 2014;84:35-44.
49. Godala MM, Materek-Kusmierkiewicz I, Moczulski D, et al. Lower plasma levels of antioxidant vitamins in patients with metabolic syndrome: a case control study. Adv Clin Exp Med. 2016;25:689-700.
50. Molnar D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord. 2004;28:1197-1202.
51. Beydoun MA, Canas JA, Beydoun HA, et al. Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys. J Nutr. 2012;142:1693-1704.
52. Li Y, Guo H, Wu M, Liu M. Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China. Asia Pac J Clin Nutr. 2013;22:60-68.
53. Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to Meta-Analysis. Chichester, UK: John Wiley & Sons; 2009.
54. Petitti DB. Statistical methods in meat-analysis. In: Petitti DB, ed. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis, 2nd ed. New York: Oxford University Press; 2000: 94-118.
55. Carter P, Gray LJ, Troughton J, et al. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;341:c4229.
56. Crowther M, Avenell A, MacLennan G, et al. A further use for the harvest plot: a novel method for the presentation of data synthesis. Res Synth Methods. 2011;2:79-83.
57. Ogilvie D, Fayter D, Petticrew M, et al. The harvest plot: a method for synthesising evidence about the differential effects of interventions. BMC Med Res Methodol. 2008;8:8.
58. Egger M, Smith GD, Altman DG. Systematic Reviews in Heatlh Care: Meta-Analysis in Context, 2nd ed. London: BMJ Publishing Group; 2001.
59. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
60. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
61. Stata Corporation. Statistics/Data Analysis: Release 14.0 [computer program]. College Station, TX: Stata Corporation; 2015.
62. Canas JA, Damaso L, Altomare A, et al. Insulin resistance and adiposity in relation to serum beta-carotene levels. J Pediatr. 2012;161:58-64.e1-2.
63. Lim HS, Shin EJ, Yeom JW, et al. Association between nutrient intake and metabolic syndrome in patients with colorectal cancer. Clin Nutr Res. 2017;6:38-46.
64. Godala M, Materek-Kusmierkiewicz I, Moczulski D, et al. Should antioxidant vitamin supplementation be applied in patients with metabolic syndrome? A casecontrol study. Prz Menopauzalny. 2016;15:32-38.
65. Wei J, Zeng C, Gong QY, et al. Associations between dietary antioxidant intake and metabolic syndrome. PLoS One. 2015;10:e0130876.
66. Park S, Ham JO, Lee BK. Effects of total vitamin A, vitamin C, and fruit intake on risk for metabolic syndrome in Korean women and men. Nutrition. 2015;31:111-118.
67. Ali R, Lee ET, Knehans AW, et al. Dietary intake among American Indians with metabolic syndrome-comparison to dietary recommendations: the balance study. Int J Health Nutr. 2013;4:33-45.
68. O'Neil CE, Nicklas TA, Rampersaud GC, et al. 100% orange juice consumption is associated with better diet quality, improved nutrient adequacy, decreased risk for obesity, and improved biomarkers of health in adults: national Health and Nutrition Examination Survey, 2003-2006. Nutr J. 2012;11:107.
69. Amini M, Esmaillzadeh A, Shafaeizadeh S, et al. Relationship between major dietary patterns and metabolic syndrome among individuals with impaired glucose tolerance. Nutrition. 2010;26:986-992.
70. Sluijs I, Beulens JW, Grobbee DE, et al. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. J Nutr. 2009;139:987-992.
71. Sesso HD. Carotenoids and cardiovascular disease: what research gaps remain? Curr Opin Lipidol. 2006;17:11-16.
72. Valtuena S, Del Rio D, Pellegrini N, et al. The total antioxidant capacity of the diet is an independent predictor of plasma beta-carotene. Eur J Clin Nutr. 2007;61:69-76.
73. Chen CC, Wu JY, Chang CT, et al. Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus. Metab Clin Exp. 2009;58:1812-1816.
74. Park K, Gross M, Lee D-H, et al. Oxidative stress and insulin resistance. Diabetes Care. 2009;32:1302-1307.
75. Palmieri VO, Grattagliano I, Portincasa P, et al. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr. 2006;136:3022-3026.
76. During A, Harrison EH. Mechanisms of provitamin A (carotenoid) and vitamin A (retinol) transport into and out of intestinal Caco-2 cells. J Lipid Res. 2007;48:2283-2294.
77. Schreiber R, Taschler U, Preiss-Landl K, et al. Retinyl ester hydrolases and their roles in vitamin A homeostasis. Biochim Biophys Acta. 2012;1821:113-123.
78. Canas JA, Lochrie A, McGowan AG, et al. Effects of mixed carotenoids on adipokines and abdominal adiposity in children: a pilot study. J Clin Endocrinol Metab. 2017;102:1983-1990.
79. Bohn T, Desmarchelier C, Dragsted LO, et al. Host-related factors explaining interindividual variability of carotenoid bioavailability and tissue concentrations in humans. Mol Nutr Food Res. 2017;61:1-37.
80. Bonet ML, Canas JA, Ribot J, et al. Carotenoids in adipose tissue biology and obesity. Subcell Biochem. 2016;79:377-414.
81. Canas JA, Damaso L, Hossain J, et al. Fatty acid binding proteins 4 and 5 in overweight prepubertal boys: effect of nutritional counselling and supplementation with an encapsulated fruit and vegetable juice concentrate. J Nutr Sci. 2015;4:e39.
82. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705-712.